Clinical Trials In Fort Worth

Discover hundreds of clinical trials in Fort Worth.
Search clinical trials in Fort Worth by condition or phase.

e.g. Respiratory Diseases

Fort Worth•Healthy volunteers: No

Filter results

Results: 1,823

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

AveXis, Inc.

Location:

Fort Worth, San Antonio, Houston, Dallasshow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

Study to Evaluate the Effects of Oral NMRA 335140 Versus Placebo in Participants With Major Depressive Disorder

Recruiting

Phase 3

Sponsor:

Neumora Therapeutics, Inc.

Location:

Wichita Falls, Houston, Dallas, Austinshow 55 more

Code:

NCT06029426

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

NMRA 335140

Placebo

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

Recruiting

Phase 3

Sponsor:

DBV Technologies

Location:

Houston, Dallas, Austin, Birminghamshow 41 more

Code:

NCT05741476

Conditions

Allergy, Peanut

Eligibility Criteria

Sex: All

Age: 4 - 7

Healthy Volunteers: Not accepted

Interventions

DBV712

Placebo

The Synergy Disc for the Treatment of 2 Level Cervical Degenerative Disc Disease Compared With Cervical Fusion Surgery

Recruiting

Sponsor:

Synergy Spine Solutions

Location:

Fort Worth, San Antonio, Plano, Austinshow 19 more

Code:

NCT05740176

Conditions

Cervical Degenerative Disc Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Anterior Cervical Discectomy and Fusion

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

Phase 3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Shenandoah, Houston, Arlington, Alabastershow 30 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

e.g. Respiratory Diseases

Fort Worth•Healthy volunteers: No

Filter results

Results: 1,823

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

AveXis, Inc.

Location:

Fort Worth, San Antonio, Houston, Dallasshow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

Study to Evaluate the Effects of Oral NMRA 335140 Versus Placebo in Participants With Major Depressive Disorder

Recruiting

Phase 3

Sponsor:

Neumora Therapeutics, Inc.

Location:

Wichita Falls, Houston, Dallas, Austinshow 55 more

Code:

NCT06029426

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

NMRA 335140

Placebo

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

Recruiting

Phase 3

Sponsor:

DBV Technologies

Location:

Houston, Dallas, Austin, Birminghamshow 41 more

Code:

NCT05741476

Conditions

Allergy, Peanut

Eligibility Criteria

Sex: All

Age: 4 - 7

Healthy Volunteers: Not accepted

Interventions

DBV712

Placebo

The Synergy Disc for the Treatment of 2 Level Cervical Degenerative Disc Disease Compared With Cervical Fusion Surgery

Recruiting

Sponsor:

Synergy Spine Solutions

Location:

Fort Worth, San Antonio, Plano, Austinshow 19 more

Code:

NCT05740176

Conditions

Cervical Degenerative Disc Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Anterior Cervical Discectomy and Fusion

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

Phase 3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Shenandoah, Houston, Arlington, Alabastershow 30 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo